Psychiatr. pro Praxi, 2006; 6: 282-284

Detoxification in the addiction to methamphetamine

MUDr. Jitka Svobodová Ph.D, Ph.D: Michael Václavík
Psychiatrické oddělení FNsP Ostrava

Methamphetamine is a stimulating drug with an indirect effect caused by the influencing of the transport mechanisms of dopamine, noradrenalin and serotonin. Neuro-adaptation mechanisms participate in the development of addiction with a predominant mental component. Abstinent syndrome during withdrawal is characterized by depression, fatigue and a lack of energy. In the next phase a strong desire for the drug appears. Although mental complications are gradually decreasing, they can last for weeks or even months. Paranoid syndrome and hallucination can be as a result of using the drug and mostly disappear spontaneously, unlike the symptoms of schizophrenic disorder. Addiction to methamphetamine is a disorder which can be treated with difficulties and with a high risk of relapse. The effect of substitution pharmacotherapy has not been proved and substances with anti-craving effect have not been commonly used so far either. A combination of biological, behavioural and psychological approaches is the most effective in the treatment, from which the ones used most are mentioned.

Keywords: methamphetamine, withdrawal, detoxification, addiction, craving

Published: February 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Svobodová J, D: Michael Václavík P. Detoxification in the addiction to methamphetamine. Psychiatr. praxi. 2006;7(6):282-284.
Download citation

References

  1. Dvořáček J. Detoxifikace. In: Kalina K. Drogy a drogové závislosti 1. Mezioborový přístup. Úřad vlády České republiky 2003; 304-309.
  2. Dvořáček J. Zvládání akutní intoxikace - speciální postupy u jednotlivých návykových látek. In: Kalina K. Drogy a drogové závislosti 1. Mezioborový přístup. Úřad vlády České republiky 2003; 297-303.
  3. Chanut F, Brown TG, Dongier M. Motivational Interviewing and Clinical Psychiatry. Canadian Journal of Psychiatry 2005; 9: 548-554. Go to original source... Go to PubMed...
  4. Fišerová M. Neurobiologie závislostí. In: Kalina K. Drogy a drogové závislosti 1. Mezioborový přístup. Úřad vlády České republiky 2003; 96-106.
  5. Galanter M, Brook D. Network therapy for addiction: Bringing family and peer support into office practice. International Journal of Group Psychotherapy 2001; 1: 101. Go to original source... Go to PubMed...
  6. Mannoni O. Freud. Olomouc: Votobia 1997; 176.
  7. Minařík J. Stimulancia. In: Kalina K. Drogy a drogové závislosti 1. Mezioborový přístup. Úřad vlády České republiky 2003; 164-168.
  8. Národní monitorovací středisko pro drogy a drogové závislosti. Situace ve věcech drog v České republice v roce 2004. Úřad vlády České republiky 2005; 12 s.
  9. Nešpor K. Problémy působené alkoholem, jinými návykovými látkami a hazardní hrou v dětství a dospívání. In: Říčan P, Krejčířová D. Dětská klinická psychologie. Praha: Grada 1997; 206.
  10. Noshpitz, JD. Self-destructiveness in adolescence. American Journal of Psychotherapy 1994; 3: 330. Go to original source... Go to PubMed...
  11. Nováková J, Šulcová A. K teorii senzitizace u látek vyvolávajících závislost. Adiktologie 2003; 2: 24-32.
  12. Praško JP, Prašková H, Vašková K, Vyskočilová J. Integrace v psychoterapii z pohledu kognitivně behaviorální terapie. In: Raboch J. (ed.) Nemocná duše - nemocný mozek: Klinická zkušenost a fakta. Praha: Galén 2006; 190 s.
  13. Sands S. Eating disorders and female development: A self-psychological perspective. In: Goldberg A. (ed.) Dimensions in self experience. Progress in Self Psychology 1989; 5: 75-102.
  14. Seymour PM. Long-term treatment of an addictive personality. Bulletin of the Menninger Clinic New York 2003; 4: 328-346. Go to original source... Go to PubMed...
  15. Šulcová A, Goldberg SR. The neurobiology of methamphetamine abuse. Adiktologie 2003; 2: 13-23.
  16. Tzschentke TM. The role of sensitization in drug addiction. Adiktologie 2003; 2: 34-48.




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.